Nehmat Ghaboura
Jeddah, 21442, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Patient Attitudes and Factors Associated with Willingness to Deprescribe Prescribed Medications in Western Saudi Arabia: A Cross-Sectional Study.
Journal: Healthcare (Basel, Switzerland)
Published: June 01, 2026
Nanogels as innovative drug carriers for RNA-based skin cancer therapy: mechanistic insights and RNA encapsulation.
Journal: Current research in translational medicine
Published: July 29, 2025
Unraveling the Hippo pathway: YAP/TAZ as central players in cancer metastasis and drug resistance.
Journal: EXCLI journal
Published: March 15, 2025
Role of IL-2, IL-6, and TNF-α as Potential Biomarkers in Ischemic Heart Disease: A Comparative Study of Patients with CAD and Non-CAD.
Journal: Medical sciences (Basel, Switzerland)
Published: January 31, 2025
Rosiridin Protects Against Aluminum Chloride-Induced Memory Impairment via Modulation of BDNF/NFκB/PI3K/Akt Pathway in Rats.
Journal: Medicina (Kaunas, Lithuania)
Published: September 30, 2024
Targeting the p53-p21 axis in liver cancer: Linking cellular senescence to tumor suppression and progression.
Journal: Pathology, research and practice
Published: September 06, 2024
Therapeutic Potential of lncRNAs in Regulating Disulfidptosis for Cancer Treatment.
Journal: Pathology, research and practice
Published: September 02, 2024
Exosomal ncRNAs in liquid biopsies for lung cancer.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: August 29, 2024
Non-coding RNAs: Key regulators of CDK and Wnt/β-catenin signaling in cancer.
Journal: Pathology, research and practice
Published: August 29, 2024
The Thematic Analysis of Barriers to Immediate Post-Partum Long-Acting Reversible Contraception.
Journal: Healthcare (Basel, Switzerland)
Published: August 26, 2024
Ginsenoside Rg3 in Cancer Research: Current Trends and Future Prospects - A Review.
Journal: Current medicinal chemistry
Published: May 29, 2024
Barbaloin Protects Pentylenetetrazol-Induced Cognitive Deficits in Rodents via Modulation of Neurotransmitters and Inhibition of Oxidative-Free-Radicals-Led Inflammation.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 22, 2024
Last Updated: 09/26/2026